Methylamine

Methylamine

SCHEMBL4067487

CCCc1ccccn1.CN

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 2/20 0.63
HRH3 Q9Y5N1 1/20 0.57
USP2 O75604 1/20 0.55
LMNA P02545 3/20 0.55
ALDH1A1 P00352 2/20 0.55
TAAR1 Q96RJ0 1/20 0.55
ALOX15 P16050 1/20 0.55
CYP1A2 P05177 3/20 0.49
CYP2C19 P33261 1/20 0.49
TDP1 Q9NUW8 3/20 0.47
KDM4E B2RXH2 2/20 0.47
TSHR P16473 2/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LIN28A Q9H9Z2 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10527 0.96
SCHEMBL29583126 0.96
SCHEMBL30101413 0.93 HRH1 (0.59) HRH1HRH3USP2LMNAALDH1A1
Iodide SCHEMBL22551708 0.93 HRH1 (0.59) HRH1HRH3USP2LMNAALDH1A1
Bromide SCHEMBL14801933 0.93 HRH1 (0.59) HRH1HRH3USP2LMNAALDH1A1
Ammonia Solution, Strong SCHEMBL1509120 0.93 HRH1 (0.59) HRH1HRH3USP2LMNAALDH1A1
SCHEMBL11564094 0.93 HRH1 (0.59) HRH1HRH3USP2LMNAALDH1A1
Hydrochloric Acid SCHEMBL28050227 0.93 ALDH1A1 (0.62) HRH1HRH3USP2LMNAALDH1A1
Bromide SCHEMBL28271951 0.91 HRH1 (0.57) HRH1HRH3USP2LMNAALDH1A1
SCHEMBL9115878 0.90 HRH1 (0.62) HRH1HRH3USP2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1326865-B1 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2009-05-06 EP disclosed
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors ANTHONY NEVILLE J (US) 2005-08-11 US disclosed
US-6921759-B2 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK & CO., INC. (US) 2005-07-26 US disclosed
EP-1326865-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2003-07-16 EP disclosed
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors MERCK SHARP & DOHME CORP. 2003-03-20 US disclosed
WO-2002030930-A2 AZA- AND POLYAZA-NAPHTHALENYL CARBOXAMIDES USEFUL AS HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 2002-04-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030055071-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA HRH1 2595/4885HRH3 2455/4885USP2 1937/4885
US-20050176718-A1 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors POLI, DUT, NAAA HRH1 2595/4885HRH3 2455/4885USP2 1937/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.